Laura E. Niklason, President, CEO and Director at Humacyte, Inc. (HUMA), sold 3,599,192 shares at $3.57 ($12.8M) on 2023-08-18, disclosed to the SEC on 2023-08-21.
Open-market sale of $12.8M HUMA by President, CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.68 | 570,174 | $2.1M | 16.4% |
| 2 | $3.68 | 570,174 | $2.1M | 16.4% |
| 3 | $3.57 | 626,979 | $2.2M | 17.5% |
| 4 | $3.57 | 626,979 | $2.2M | 17.5% |
| 5 | $3.39 | 602,443 | $2.0M | 16.0% |
| 6 | $3.39 | 602,443 |
| $2.0M |
| 16.0% |
| Total | $3.54 avg | 3,599,192 | $12.8M | 100% |
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |